... Food and Drug Administration
HIV Pre-Exposure Prophylaxis — Wolters Kluwer UpToDate
¿Quién tiene probabilidad de adquirir el VIH? — HIV.gov
Human Immunodeficiency Virus (HIV) Infection: Screening — U.S. ...
... Neuropharmacology
Potential Adverse Drug Events and Drug-Drug Interactions With Medical and Consumer Cannabidiol (CBD) Use — Journal of Clinical Medicine
The Effects of Cannabinoids on the Pharmacokinetics of Indinavir and Nelfinavir — AIDS
...
CBD para el VIH: ¿es eficaz?
... Neuropharmacology
Potential Adverse Drug Events and Drug-Drug Interactions With Medical and Consumer Cannabidiol (CBD) Use — Journal of Clinical Medicine
The Effects of Cannabinoids on the Pharmacokinetics of Indinavir and Nelfinavir — AIDS
...
... — HIV.gov
Associations Between Sexual Partner Number and HIV Risk Behaviors: Implications for HIV Prevention Efforts in a Treatment as Prevention (TasP) Environment — AIDS Care
HIV Testing Overview — HIV.gov
Understanding the HIV Window Period — Centers for Disease Control and Prevention
Understanding Your HIV Test Results — HIV.gov
Preventing Sexual ...
Datos sobre el VIH negativo: ¿Puede contraer el VIH si usted y su pareja son negativos?
... — HIV.gov
Associations Between Sexual Partner Number and HIV Risk Behaviors: Implications for HIV Prevention Efforts in a Treatment as Prevention (TasP) Environment — AIDS Care
HIV Testing Overview — HIV.gov
Understanding the HIV Window Period — Centers for Disease Control and Prevention
Understanding Your HIV Test Results — HIV.gov
Preventing Sexual ...
... of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds — International Journal of Molecular Sciences
HIV Vaccines — HIV.gov
Trends in HIV-2 Diagnoses and Use of the HIV-1/HIV-2 Differentiation Test — United States, 2010-2017 — Morbidity and Mortality Weekly Report
Treatment of HIV-2 Infection — Wolters Kluwer UpToDate ...
VIH-1 frente a VIH-2: ¿Cuáles son las diferencias y puede tener ambas?
... of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds — International Journal of Molecular Sciences
HIV Vaccines — HIV.gov
Trends in HIV-2 Diagnoses and Use of the HIV-1/HIV-2 Differentiation Test — United States, 2010-2017 — Morbidity and Mortality Weekly Report
Treatment of HIV-2 Infection — Wolters Kluwer UpToDate ...
... — Mayo Clinic
HIV Infection and Cancer Risk — National Cancer Institute
Herpes: HSV-1 and HSV-2 — Johns Hopkins Medicine
QuickFacts: United States — United States Census Bureau
U.S. Statistics — HIV.gov ...
Herpes vs. VIH: ¿Cuál es la diferencia?
... — Mayo Clinic
HIV Infection and Cancer Risk — National Cancer Institute
Herpes: HSV-1 and HSV-2 — Johns Hopkins Medicine
QuickFacts: United States — United States Census Bureau
U.S. Statistics — HIV.gov ...
... Referencias
Early HIV Diagnosis and Treatment Important for Better Long-Term Health Outcomes — National Institutes of Health
Los síntomas del VIH — HIV.gov
Acute and Early HIV Infection: Clinical Manifestations and Diagnosis — Wolters Kluwer UpToDate
Síntomas iniciales del VIH: ¿qué son? ...
Dolor de garganta y VIH: ¿es un síntoma temprano?
... Referencias
Early HIV Diagnosis and Treatment Important for Better Long-Term Health Outcomes — National Institutes of Health
Los síntomas del VIH — HIV.gov
Acute and Early HIV Infection: Clinical Manifestations and Diagnosis — Wolters Kluwer UpToDate
Síntomas iniciales del VIH: ¿qué son? ...
... Adolescents With HIV — HIVinfo.NIH.gov
VIH/sida — Mayo Clinic
AIDS and Opportunistic Infections — Centers for Disease Control and Prevention
Tips for Taking Your HIV Meds, on Time, All the Time — HIVinfo.NIH.gov
Transmitted Drug Resistance Among Human Immunodeficiency Virus (HIV)-1 Diagnoses in the United States, 2014-208 — Clinical Infectious Diseases ...
Resistencia farmacológica al VIH: Mutaciones, pruebas, síntomas, y más
... Adolescents With HIV — HIVinfo.NIH.gov
VIH/sida — Mayo Clinic
AIDS and Opportunistic Infections — Centers for Disease Control and Prevention
Tips for Taking Your HIV Meds, on Time, All the Time — HIVinfo.NIH.gov
Transmitted Drug Resistance Among Human Immunodeficiency Virus (HIV)-1 Diagnoses in the United States, 2014-208 — Clinical Infectious Diseases ...
... — Institutos Nacionales de Salud (NIH)
México refuerza el acceso universal al diagnóstico y tratamiento del VIH y SIDA — ConsultorSalud
HIV Testing and Outcomes Among Hispanics/Latinos; United States, Puerto Rico, and U.S. ...
¿El VIH puede detectarse en cualquier análisis de sangre?
... — Institutos Nacionales de Salud (NIH)
México refuerza el acceso universal al diagnóstico y tratamiento del VIH y SIDA — ConsultorSalud
HIV Testing and Outcomes Among Hispanics/Latinos; United States, Puerto Rico, and U.S. ...
... — Centers for Disease Control and Prevention
...
únete
